Designs

The aim of this research is to present both a sensorless control and a torque derating algorithm in the overload region of a permanent magnet motor for e-bikes. First, the theoretical backgrounds and the field-oriented control are presented. Then, a sensorless control is designed based on the back-emf estimation with a second-order generalized integral flux observer for the permanent magnet motor. The second-order generalized integral flux observer is an adaptive filter which can eliminate the DC offset and strongly attenuate the harmonics of the estimated rotor flux. The algorithms have been simulated and then validated by means of tests on a permanent magnet motor for e-bikes.

Multifunctional aerostructures that carry mechanical loadings while conducting electrical currents offer a promising approach to reduce the weight of Electrical Power Systems (EPS) of aircraft. However, Carbon Fibre-Reinforced Polymer (CFRP), when used for aerostructures, presents challenges in achieving multi-functionality due to anisotropic mechanical, electrical, and thermal properties. These properties are interdependent on both laminate-level design factors (fibre/resin choice, fibre volume fraction, stacking sequence, and electrode configuration) and system-level EPS constraints (allowable voltage drop, current, and installation geometry). State-of-the-art material design and selection methods lack a coupled mechanical–electro–thermal design and selection approach to overcome these challenges of a complex design space to enable identification of multifunctional CFRP (MF-CFRP) solutions. This paper presents the first methodology for the design and selection of MF-CFRP with combined electrical, structural, and thermal properties. The methodology integrates requirement capture, laminate layup determination, electro-thermal assessment, option ranking, and manufacturing route selection. The methodology couples laminate-level design factors with system-level EPS constraints and includes iterative loops to refine either the CFRP design or the EPS parameters when no solution initially exists. The methodology is demonstrated to enable the design of a CFRP component to conduct the electrical current as part of the 28 V_DC network in an aircraft. This case study demonstrates the value of the methodology to identify knowledge and dataset gaps necessary for MF-CFRP design, alongside enabling the design of MF-CFRP components to enable increased power density of weight-critical EPS. Although the case study focused on a 28 V_DC system, the methodology is generalisable to other aircraft electrical architectures since system-level electrical parameters are used within the methodology as adaptable inputs.

Glaucoma is recognized as the second leading cause of blindness globally and a primary cause of irreversible blindness, estimated to affect over 80 million patients worldwide, including 4.5 million in the United States. Though the disease is multifactorial, the primary cause is elevated intraocular pressure (IOP), which damages the optic nerve fibers that connect the eye to the brain, thus interfering with the quality of vision. Current treatments have evolved, which consist of medications, laser therapies, and surgical interventions such as filtering procedures, glaucoma drainage devices (GDDs), and current innovations of minimally invasive glaucoma surgeries (MIGS). This paper aims to discuss the history and evolution of the design and biomaterials employed in GDDs and MIGS. Through a comprehensive review of the literature, we trace the development of these devices from early concepts to modern implants, highlighting advancements in materials science and surgical integration. This historical analysis, ranging from the mid-19th century, reveals a trend towards enhanced biocompatibility, improved efficiency in IOP reduction, and reduced complications. We conclude that the ongoing evolution of GDDs and MIGS underscores a persistent commitment to advancing patient care in glaucoma, paving the way for future device innovations and therapeutic trends to treat glaucoma.